Syensqo releases 2024 annual integrated report

Syensqo releases 2024 annual integrated report

Brussels, Belgium – March 28, 2025 - 08:30 CET

Syensqo has published its 2024 annual integrated report today giving its stakeholders a comprehensive and integrated overview of the company's strategy, business activities and performance for its first year. 

The report comprises the company’s financial and extra-financial statements, compliant with the EU Corporate Sustainability Reporting Directive (CSRD), One Planet roadmap progress on Climate, Nature, Growth, and Better Life.

The 2024 annual integrated report is posted in the Financials section of the Syensqo website. A European Single Electronic Format (ESEF) as required by EU Regulation 2019/815 is also available for download.

Contacts

About Syensqo 

Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates.
Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and health care applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.

Investor Relations sources

• Earnings materials
• Strategy
• Share information
• Credit information
• Separation documents
• Webcasts, podcasts and presentations
• 2024 Annual Integrated Report
• Subscribe to our distribution list

Attachments

• 20250328_SYENSQO_2024_Annual Report_EN
• Syensqo_AIR_2024_EN_for upload_27032025_WA

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Following HYCU® aiR™ Launch, HYCU Names Anant Chintamaneni Chief Product Officer to Accelerate AI Resilience Strategy
• Cosmos Health posts 29% revenue rise in Q2 but net loss widens